Leveraging real-world data (RWD) can improve recruitment workflows and outcomes in DCTs.

In this session, John Reites, CEO of THREAD, and Matt Walz, CEO of Trialbee, discuss the value of de-identified EMR and how it can be used to enhance digital outreach, as well as, strategies that help patients and physicians engage with their own data to enhance recruitment in DCT.

Watch the session to learn:

• How to leverage RWD to improve recruitment workflows and outcomes in DCTs
• The value of de-identified EMR and how it can be used to enhance digital outreach
• Strategies that help patients and physicians engage with their own data to enhance recruitment in DCT

Industry Recognition

Winner of Frost & Sullivan’s “2021 Customer Value Leadership Award” for excellence in the decentralized clinical trials industry and THREAD Named Leader by Everest Group in the Decentralized Clinical Trial Products PEAK Matrix® Assessment. Read more.